Business
Press Release Aug 30 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 30, 2023, titled \"Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension\". View Attachment","length":341,"tagName":"div"}]